- Home
- YMAB vs SRG Comparison
YMAB vs SRG Comparison
Compare YMAB & SRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- SRG
- Stock Information
- Founded
- YMAB 2015
- SRG 2014
- Country
- YMAB United States
- SRG United States
- Employees
- YMAB N/A
- SRG N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- SRG Real Estate Investment Trusts
- Sector
- YMAB Health Care
- SRG Real Estate
- Exchange
- YMAB Nasdaq
- SRG Nasdaq
- Market Cap
- YMAB 192.4M
- SRG 163.3M
- IPO Year
- YMAB 2018
- SRG 2015
- Fundamental
- Price
- YMAB $4.36
- SRG $3.05
- Analyst Decision
- YMAB Buy
- SRG
- Analyst Count
- YMAB 11
- SRG 0
- Target Price
- YMAB $17.55
- SRG N/A
- AVG Volume (30 Days)
- YMAB 202.0K
- SRG 91.5K
- Earning Date
- YMAB 08-11-2025
- SRG 08-13-2025
- Dividend Yield
- YMAB N/A
- SRG N/A
- EPS Growth
- YMAB N/A
- SRG N/A
- EPS
- YMAB N/A
- SRG N/A
- Revenue
- YMAB $88,658,000.00
- SRG N/A
- Revenue This Year
- YMAB N/A
- SRG N/A
- Revenue Next Year
- YMAB $15.15
- SRG N/A
- P/E Ratio
- YMAB N/A
- SRG N/A
- Revenue Growth
- YMAB 4.92
- SRG N/A
- 52 Week Low
- YMAB $3.55
- SRG $2.43
- 52 Week High
- YMAB $16.11
- SRG $5.52
- Technical
- Relative Strength Index (RSI)
- YMAB 45.29
- SRG 58.29
- Support Level
- YMAB $4.10
- SRG $2.94
- Resistance Level
- YMAB $4.62
- SRG $3.18
- Average True Range (ATR)
- YMAB 0.29
- SRG 0.11
- MACD
- YMAB -0.04
- SRG 0.01
- Stochastic Oscillator
- YMAB 20.73
- SRG 78.13
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About SRG Seritage Growth Properties
Seritage Growth Properties is principally engaged in the ownership, development, redevelopment, management, and leasing of diversified and mixed-use properties throughout the United States.